Cargando…
Gut Microbiota and Immunotherapy
The gut microbiota is the largest microbiota in the body, which is closely related to the immune state of the body. A number of studies have shown that gut microbiota and its metabolites are involved in host immune regulation. Immune checkpoint inhibitors have become an important drug for the treatm...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9283110/ https://www.ncbi.nlm.nih.gov/pubmed/35847121 http://dx.doi.org/10.3389/fmicb.2022.945887 |
_version_ | 1784747263643353088 |
---|---|
author | Xu, Xiaoqing Ying, Jieer |
author_facet | Xu, Xiaoqing Ying, Jieer |
author_sort | Xu, Xiaoqing |
collection | PubMed |
description | The gut microbiota is the largest microbiota in the body, which is closely related to the immune state of the body. A number of studies have shown that gut microbiota and its metabolites are involved in host immune regulation. Immune checkpoint inhibitors have become an important drug for the treatment of many malignant tumors, which can significantly improve the prognosis of tumor patients. However, a considerable number of patients cannot benefit from immune checkpoint inhibitors. At present, the known treatment methods of microbiota manipulation mainly include fecal microbiota transplantation, dietary regulation, prebiotics and so on. Therefore, this paper will discuss the possibility of improving the anti-tumor efficacy of immunotherapy from the perspectives of the gut microbiota and immunotherapy. |
format | Online Article Text |
id | pubmed-9283110 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-92831102022-07-16 Gut Microbiota and Immunotherapy Xu, Xiaoqing Ying, Jieer Front Microbiol Microbiology The gut microbiota is the largest microbiota in the body, which is closely related to the immune state of the body. A number of studies have shown that gut microbiota and its metabolites are involved in host immune regulation. Immune checkpoint inhibitors have become an important drug for the treatment of many malignant tumors, which can significantly improve the prognosis of tumor patients. However, a considerable number of patients cannot benefit from immune checkpoint inhibitors. At present, the known treatment methods of microbiota manipulation mainly include fecal microbiota transplantation, dietary regulation, prebiotics and so on. Therefore, this paper will discuss the possibility of improving the anti-tumor efficacy of immunotherapy from the perspectives of the gut microbiota and immunotherapy. Frontiers Media S.A. 2022-07-01 /pmc/articles/PMC9283110/ /pubmed/35847121 http://dx.doi.org/10.3389/fmicb.2022.945887 Text en Copyright © 2022 Xu and Ying. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Microbiology Xu, Xiaoqing Ying, Jieer Gut Microbiota and Immunotherapy |
title | Gut Microbiota and Immunotherapy |
title_full | Gut Microbiota and Immunotherapy |
title_fullStr | Gut Microbiota and Immunotherapy |
title_full_unstemmed | Gut Microbiota and Immunotherapy |
title_short | Gut Microbiota and Immunotherapy |
title_sort | gut microbiota and immunotherapy |
topic | Microbiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9283110/ https://www.ncbi.nlm.nih.gov/pubmed/35847121 http://dx.doi.org/10.3389/fmicb.2022.945887 |
work_keys_str_mv | AT xuxiaoqing gutmicrobiotaandimmunotherapy AT yingjieer gutmicrobiotaandimmunotherapy |